Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1110 participants.
Also called NCT01828697
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 1,110 participants
- Registry
-
NCT01828697 -
2012-001505-24
-
- Other papers using this trial's data
- Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial
- Onset of labor and use of analgesia in women using thromboprophylaxis with 2 doses of low-molecular-weight heparin: insights from the Highlow study
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Belgium, Canada, Denmark, France, Ireland, Netherlands, Norway, Russia, Spain
- Registry status
- Completed
Technical summary
Registry record NCT01828697. Randomized; no masking; primary purpose prevention. Start 2013-04-24 (actual); primary completion 2021-10-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
- Acronym
- Highlow
- Condition
- Deep Venous Thrombosis
- Condition
- Pulmonary Embolism
- Intervention (Drug)
- Low dose nadroparin
- Intervention (Drug)
- Intermediate dose nadroparin
- Intervention (Drug)
- Low dose enoxaparin
- Intervention (Drug)
- Intermediate dose enoxaparin
- Intervention (Drug)
- Low dose dalteparin
- Intervention (Drug)
- Intermediate dose dalteparin
- Intervention (Drug)
- Fixed low dose tinzaparin
- Intervention (Drug)
- Intermediate dose tinzaparin
- Lead sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Collaborator
- Netherlands Organisation for Scientific Research
- Collaborator
- Aspen Pharma
- Collaborator
- CHU of Saint Etienne: French Ministry of Health Grant (sponsor of the French part of the study)
- Collaborator
- Rotunda Hospital: Definitive Interventions and Feasibility Awards (DIFA) 2017 (sponsor of the Irish part of the study))
Record details
- Record id
cardio:ct-nct01828697- Content hash
e569221cf7b4cd0aa3045a675f4aec8592dee8d0ecb7e6c67812302b94b49094